Podcast Episodes

Back to Search
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review


Season 24 Episode 13


Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of…


Published on 10 months, 2 weeks ago

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors


Season 24 Episode 12


Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landsc…


Published on 11 months ago

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers


Season 24 Episode 11


Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texa…


Published on 1 year ago

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors


Season 24 Episode 10


Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, O…


Published on 1 year ago

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers


Season 24 Episode 9


Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of …


Published on 1 year ago

Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma

Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma


Season 24 Episode 8


Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other…


Published on 1 year ago

RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer


Season 24 Episode 7


Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel …


Published on 1 year, 2 months ago

Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer


Season 24 Episode 6


Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.


Published on 1 year, 4 months ago

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition


Season 24 Episode 5


Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal canc…


Published on 1 year, 5 months ago

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer


Season 24 Episode 4


Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and nov…


Published on 1 year, 5 months ago





If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate